Komori
Susmed (4263) · RiskWorsened

Persistent Negative Operating Cash Flow and Impairment of Company-Wide Assets

First written in FY2022-Q2. 7 of 17 entries say "Worsened", first in FY2022-Q3. Latest entry: FY2026.

17entries
5years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2022-Q2 – FY2022OtherFY2024-Q2 – FY2024WorsenedFY2025-H1 – FY20252022: 420222023: 420232024: 320242025: 220252026: 42026
Same theme, other companies
Impairment Losses on Shared-Use and Corporate AssetsA theme 12 companies write about · 12 as a headwind · 0 as a tailwind

Susmed moved to the "Worse" side of this theme in 2022, 2 years before the typical company in this theme (2024).

The whole theme swung hardest in 2024: 2 of 8 companies on the "Worse" side.

0 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026WorsenedAnnual report

    「In addition, because operating cash flow has remained negative and the total undiscounted future cash flows are expected to fall below the carrying amount, the company recognized an impairment loss of ¥67.471 million on all company-wide assets as an extraordinary loss.」

    Operating cash flow outflows increased to ¥474.454 million, and the impairment loss also increased substantially to ¥67.471 million.
  2. FY2026-H1Impairment losses declined, but negative operating cash flow and impairment recognition continuedAnnual report

    「In addition, because operating cash flow has remained negative and total undiscounted future cash flows are expected to fall below the carrying amount, we have recognized impairment losses on corporate assets. The impairment loss consisted of ¥1.674 million on tools, furniture and fixtures.」

    Impairment recognition due to continued negative operating cash flow continued, but the impairment loss declined from ¥3.376 million in the same period of the previous year to ¥1.674 million.
  3. FY2025WorsenedAnnual report

    「Cash used in operating activities amounted to ¥432.477 million, compared with ¥230.762 million used in the previous fiscal year. In addition, because operating cash flow for the corporate assets, consisting of tools, furniture and fixtures, remained negative, and after reviewing the future recoverability of the operating assets, consisting of software, we expected total undiscounted future cash flows to fall below the carrying amount and recognized an impairment loss of ¥4.706 million under extraordinary losses.」

    Cash used in operating activities increased from ¥230.762 million in the previous fiscal year to ¥432.477 million, and the company recognized a ¥4.706 million impairment loss on corporate and operating assets.
  4. FY2025-H1WorsenedAnnual report

    「Cash used in operating activities amounted to ¥275.242 million, compared with ¥21.447 million generated in the previous interim accounting period.」

    Operating cash flow changed from ¥21.447 million generated in the same period of the previous year to ¥275.242 million used. The company also recognized total impairment losses of ¥3.376 million on corporate assets and operating assets.
  5. FY2024Operating cash flow turned negative again, and impairment recognition continuedAnnual report

    「Cash used in operating activities amounted to ¥230.762 million, compared with ¥100.591 million generated in the previous fiscal year. In addition, after reviewing the future recoverability of the company's corporate assets, we determined that total undiscounted future cash flows would fall below the carrying amount and recognized an impairment loss of ¥2.726 million.」

    Operating cash flow changed from ¥100.591 million generated in the previous fiscal year to ¥230.762 million used, and the company also recognized a ¥2.726 million impairment loss on corporate assets.
  6. FY2024-Q3Impairment losses declined, but negative operating cash flow and impairment recognition continuedAnnual report

    「In addition, because operating cash flow has remained negative and total undiscounted future cash flows are expected to fall below the carrying amount, we have recognized impairment losses on corporate assets. The impairment loss consisted of ¥1.848 million on tools, furniture and fixtures.」

    Impairment recognition on corporate assets due to continued negative operating cash flow continued. Meanwhile, the impairment loss declined from ¥3.931 million in the cumulative period of the same quarter of the previous year to ¥1.848 million.
  7. FY2024-Q2Operating cash flow turned positive, but impairment recognition continuedAnnual report

    「Cash generated from operating activities amounted to ¥21.447 million, compared with ¥93.546 million used in the same quarter of the previous year. The main factors increasing cash were increases of ¥107.558 million in contract liabilities, ¥14.869 million in accounts payable and ¥8.936 million in share-based compensation expenses, among others. The main factors reducing cash were a pretax quarterly net loss of ¥90.792 million and other items totaling ¥16.615 million, among others.」

    Cash flow from operating activities changed from ¥93.546 million used in the same quarter of the previous year to ¥21.447 million generated. Meanwhile, recognition of an ¥895,000 impairment loss on corporate assets due to continued negative operating cash flow continued.
  8. FY2024-Q1MaterialisedAnnual report

    「Because our operating cash flow has remained negative and total undiscounted future cash flows are expected to fall below carrying amounts, we have recognized impairment losses on assets company-wide.」

    Due to continued negative operating cash flow, the company recognized an impairment loss of ¥895,000 during the cumulative first quarter. The amount declined from ¥1.097 million in the previous first quarter, but impairment recognition continued.
  9. FY2023MitigatedAnnual report

    「Cash generated from operating activities amounted to ¥100.591 million, compared with ¥165.283 million used in the previous fiscal year.」

    Operating cash flow changed from ¥165.283 million used in the previous fiscal year to ¥100.591 million generated. Meanwhile, the company recognized a ¥5.426 million impairment loss on corporate assets.
  10. FY2023-Q3WorsenedAnnual report

    「In addition, because operating cash flow has remained negative and total undiscounted future cash flows are expected to fall below the carrying amount, we have recognized impairment losses on corporate assets. The impairment loss consisted of ¥3.931 million on tools, furniture and fixtures.」

    Impairment recognition due to continued negative operating cash flow continued, and the impairment loss increased from ¥2.321 million in the previous cumulative quarter to ¥3.931 million.
  11. FY2023-Q2RestatedAnnual report

    「In addition, because operating cash flow has remained negative and total undiscounted future cash flows are expected to fall below the carrying amount, we have recognized impairment losses on corporate assets. The impairment loss consisted of ¥2.321 million on tools, furniture and fixtures.」

    Impairment recognition on corporate assets due to continued negative operating cash flow continued, with the impairment loss for the six months ended the second quarter amounting to ¥2.321 million. Cash used in operating activities also amounted to ¥93.546 million.
  12. FY2023-Q1RestatedAnnual report

    「Because our operating cash flow has remained negative and total undiscounted future cash flows are expected to fall below carrying amounts, we have recognized impairment losses on assets company-wide.」

    Impairment recognition on corporate assets due to continued negative operating cash flow continued, with the impairment loss for the quarter amounting to ¥1.097 million.
  13. FY2022WorsenedAnnual report

    「Cash used in operating activities amounted to ¥165.283 million, compared with ¥235.088 million used in the previous fiscal year.」

    Negative operating cash flow continued, and the impairment loss on fixed assets increased to ¥15.719 million.
  14. FY2022-Q3WorsenedAnnual report

    「Because operating cash flow has remained negative and total undiscounted future cash flows are expected to fall below the carrying amount, we reduced the carrying amount of corporate assets not allocated to segments to their recoverable amount and recognized the decrease as an impairment loss under extraordinary losses. The impairment loss recognized during the nine months ended the third quarter was ¥15.362 million.」

    Negative operating cash flow and impairment recognition for corporate assets continued, with the impairment loss increasing from ¥14.795 million previously to ¥15.362 million.
  15. FY2022-Q2MaterialisedAnnual report

    「Because operating cash flow has remained negative and total undiscounted future cash flows are expected to fall below the carrying amount, we reduced the carrying amount of corporate assets not allocated to segments to their recoverable amount and recognized the decrease as an impairment loss under extraordinary losses. The impairment loss recognized during the six months ended the second quarter was ¥14.795 million.」

    The company states that it recognized a ¥14.795 million impairment loss against a backdrop of continued negative operating cash flow.
Moved together

"Increase in Business Revenue and Narrower Losses" moved the same way as this thread, in the same document, in 5 of its 17 moves.

533222★123456
  1. ★This thread
  2. 1Increase in Business Revenue and Narrower Losses5×
  3. 2Continued Lack of Stable Revenue Sources and Negative Operating Cash Flow3×
  4. 3Uncertainty in the Business Environment Due to COVID-193×
  5. 4Policy of Using Development Pipeline Volume and Clinical Trial Progress as Important Management Indicators2×
  6. 5Delay to Part of the Recruitment Plan Due to Intensifying Competition for Talent2×
  7. 6Dilution of Per-Share Value Through Exercise of Stock Acquisition Rights and Additional Share Issuances2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Susmed yet. It last moved in the Earnings of 2026-08-07: "Worsened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Persistent Negative Operating Cash Flow and Impairment of Company-Wide Assets | SUSMED,Inc. (4263) | Komori